KEMSTRO
LOE ApproachingNDAORALTABLET, ORALLY DISINTEGRATING
Approved
Oct 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KEMSTRO is an orally disintegrating tablet formulation of baclofen, a small-molecule GABA analog used to treat skeletal muscle spasm from rheumatic disorders. It works by inhibiting monosynaptic and polysynaptic reflexes at the spinal level, though its precise mechanism remains incompletely understood. The drug offers a convenient dosing option that can dissolve on the tongue without water.
LOE Approaching
Product is nearing loss of exclusivity with moderate competitive pressure (30%), signaling potential team consolidation and shift toward generic optimization or exit strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis
Started Jan 2005
60 enrolled
Multiple Sclerosis
Career Relevance
Working on KEMSTRO in its LOE-approaching phase offers exposure to defensive commercial strategy, generic transition management, and managed care negotiation—valuable skills for career mobility. However, limited open positions and declining market dynamics suggest this is better suited as a rotational assignment than a long-term career anchor.
Brand Manager
Worked on KEMSTRO at UCB Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.